Table 2.
Proportions (%) of women (numbers) with outcomes suggesting malaria during pregnancy, and OR and 95% CIs for group effect, n=4326
| Outcomes | Second visit* % (n) |
Third visit† % (n) |
Between the first and fifth visit‡ OR (95% CI) | ||||
|---|---|---|---|---|---|---|---|
| Selective iron n=1455 | Routine iron n=1494 | Selective iron n=1040 | Routine iron n=1106 | Selective iron | Routine iron | p Value | |
| Fever | 11.5 (168) | 10.0 (150) | 11.3 (117) | 12.1 (134) | 1.00 | 0.95 (0.81 to 1.11) | 0.523 |
| Headache | 24.9 (363) | 24.3 (363) | 24.9 (259) | 25.1 (278) | 1.00 | 0.98 (0.87 to 1.10) | 0.738 |
| Cold/chills | 8.2 (120) | 7.0 (104) | 6.7 (70) | 7.8 (86) | 1.00 | 0.92 (0.76 to 1.11) | 0.361 |
| Vomit/nausea | 9.1 (133) | 10.2 (153) | 8.5 (88) | 9.6 (109) | 1.00 | 1.09 (0.92 to 1.31) | 0.323 |
| Body aches | 10.1 (147) | 9.2 (138) | 10.9 (113) | 9.8 (108) | 1.00 | 0.89 (0.75 to 1.06) | 0.180 |
| Self-reported malaria | 2.4 (35) | 3.0 (45) | 1.5 (16) | 2.2 (24) | 1.00 | 1.37 (0.98 to 1.92) | 0.068 |
*Between the first and second visit.
†Between the second and third visit.
‡The effect estimates calculated by binomial generalised estimating equations (with exchangeable correlation structure) to account for the repeated measures of the outcomes.